Alon Ruth 4
4 · Silexion Therapeutics Corp · Filed Feb 23, 2026
Research Summary
AI-generated summary of this filing
Silexion (SLXN) Director Alon Ruth Receives RSUs & Option Grant
What Happened
Alon Ruth, a director of Silexion Therapeutics Corp., received two compensation awards on Feb 20, 2026: 9,091 fully vested restricted share units (RSUs) that were immediately settled for underlying ordinary shares, and an option grant covering 10,685 shares. The Form 4 shows $0.00 as the acquisition price for both items (this reflects the grant/compensation reporting on the form, not the market value).
Key Details
- Transaction date(s): 2026-02-20 (reported on Form 4 filed 2026-02-23).
- Items granted: 9,091 shares (RSUs immediately settled for shares) and options to purchase 10,685 shares.
- Price shown on form: $0.00 for both entries (compensation grant reporting).
- Vesting/expiration for options: options vest in full on the one‑year anniversary of the grant and expire on the ten‑year anniversary (footnote F3).
- Footnotes: F1 confirms RSUs were fully vested and immediately settled; F2 describes the option grant; F4 notes certain reported holdings/rows are informational only.
- Post‑transaction holdings: not specified in the excerpt provided.
Context
These transactions are compensation grants to a director (coded “A” for award/grant), which are common for board service and do not represent an open‑market purchase or sale. The option is a derivative award that will vest after one year; no exercise or sale is reported. The $0.00 amount on the filing indicates grant reporting and should not be interpreted as market value.
Insider Transaction Report
- Award
Ordinary Shares
[F1]2026-02-20+9,091→ 10,228 total - Award
Stock Option (right to buy Ordinary Shares)
[F2][F3]2026-02-20+10,685→ 10,685 totalExercise: $1.65From: 2027-02-12Exp: 2036-02-12→ Ordinary Shares (10,685 underlying)
- 935
Stock Option (right to buy Ordinary Shares)
[F4]Exercise: $18.90From: 2026-02-09Exp: 2035-02-09→ Ordinary Shares (935 underlying)
Footnotes (4)
- [F1]The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of fully vested restricted share units (RSUs), which were immediately settled for underlying ordinary shares, par value $0.0135 per share ("ordinary shares"), in respect of the Reporting Person's services as a director of the Issuer. The grant was approved by the Issuer's board of directors.
- [F2]The transaction reported in this row consists of the grant to the Reporting Person by the Issuer of options to purchase ordinary shares, in respect of the Reporting Person's services as a director of the Issuer, which grant was approved by the Issuer's board of directors.
- [F3]The options reported in this row vest in their entirety on the one-year anniversary of, and expire on the ten-year anniversary of, the date of approval of their grant by the Issuer's board of directors.
- [F4]There were no transactions effected in respect of the securities reported in this row, and the holdings in this row are being included for informational purposes only.